Scinai Immunotherapeutics Share Are Trading Higher After the Company Announced Today the Establishment of a U.S.-based Subsidiary for Its Contract Development and Manufacturing Services.
Scinai Immunotherapeutics Share Are Trading Higher After the Company Announced Today the Establishment of a U.S.-based Subsidiary for Its Contract Development and Manufacturing Services.
Scinai免疫治療公司在今天宣佈成立一個美國子公司，專注於其合同開發和製造服務後，股票交易價格上漲。
Scinai Immunotherapeutics Share Are Trading Higher After the Company Announced Today the Establishment of a U.S.-based Subsidiary for Its Contract Development and Manufacturing Services.
Scinai免疫治療公司在今天宣佈成立一個美國子公司，專注於其合同開發和製造服務後，股票交易價格上漲。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間